Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group

Document type :
Journal articles
Complete list of metadatas

https://hal.archives-ouvertes.fr/hal-02123075
Contributor : Dominique Chadeyron <>
Submitted on : Tuesday, May 7, 2019 - 5:03:44 PM
Last modification on : Wednesday, May 8, 2019 - 1:30:52 AM

Links full text

Identifiers

Collections

Citation

Lionel Adès, Xavier Thomas, Agnes Guerci Bresler, Emmanuel Raffoux, Olivier Spertini, et al.. Arsenic trioxide is required in the treatment of newly diagnosed acute promyelocytic leukemia. Analysis of a randomized trial (APL 2006) by the French Belgian Swiss APL group. Haematologica, Ferrata Storti Foundation, 2018, 103 (12), pp.2033-2039. ⟨10.3324/haematol.2018.198614⟩. ⟨hal-02123075⟩

Share

Metrics

Record views

7